Oppenheimer Initiates Coverage of Harpoon Therapeutics (HARP) with Outperform Recommendation
Fintel reports that on January 5, 2024, Oppenheimer initiated coverage of Harpoon Therapeutics (NasdaqCM:HARP) with a Outperform recommendation.
Symbol | Last Price | Change | % Change |
---|---|---|---|